From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

Canada: A recent longitudinal analysis based on the Study of Women’s Health Across the Nation (SWAN) cohort has shed light on ...

Pune: Pune police have cited ''ambiguity'' and sought clarity from Sassoon General Hospital (SGH) in the latter's report on ...

USFDA, via email communication dated 11th April, 2025 (received by Medispray), has classified the inspection at the ...

Jai Corp Limited has received Rs. 362.72 crore net of tax deducted at source from Urban Infrastructure Private Limited today ...

The NHS saved nearly £99.4 million by using Infliximab, the biosimilar version of Jannssen’s Remicade and £60 million by switching from Amgen/Pfizer’s Enbrel to Etanercept.